Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Avalon Globocare (ALBT)

Avalon Globocare (ALBT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
The Five Biotech Stocks Every Investor Should Know About

Avalon GloboCare Corp., (NASDAQ: ALBT) a developer of innovative precision diagnostics and provider of clinical laboratory services just announced that the United States Patent and Trademark Office (USPTO)...

ALBT : 0.4410 (-6.37%)
INSM : 76.19 (+1.51%)
VIR : 10.01 (-2.05%)
CODX : 1.2600 (-0.79%)
ANTX : 2.82 (-1.23%)
Stocks in play: Avalon GloboCare Corp.

Announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Publication ...

ALBT : 0.4410 (-6.37%)
Stocks in play: Avalon GloboCare Corp.

Announced that Laboratory Services MSO, LLC is now offering an in-house laboratory developed test to ...

ALBT : 0.4410 (-6.37%)
A Potentially Revolutionary Tuberculosis Test Can Produce Results in 24 Hours

With a rising prevalence of chronic diseases, we’re starting to see higher demand for clinical lab services. That being said, it’s no surprise that, according to Market.Us, the global market for clinical...

INSM : 76.19 (+1.51%)
VIR : 10.01 (-2.05%)
CODX : 1.2600 (-0.79%)
ANTX : 2.82 (-1.23%)
ALBT : 0.4410 (-6.37%)
Revere Securities served as M&A Advisor for $31MM Avalon Globalcare Corp merger

/PRNewswire/ -- Revere Securities is pleased to announce that it served as a Merger and Acquisition advisor of $31MM transaction for Avalon Globalcare corp....

ALBT : 0.4410 (-6.37%)

Barchart Exclusives

Buy This Precious Metal ETF to Benefit from Booming Hybrid Vehicle Sales
U.S. hybrid sales have risen at a torrid 35% year on year rate so far in 2024. According to S&P Global Mobility data cited by Reuters, hybrid sales are expected to more than triple over the next five years, and make up 24% of U.S. new car sales in 2028. That's great news for platinum demand - and this physical platinum ETF is the way to play this trend. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar